Back
EyePoint Pharmaceuticals Vs. Bel Fuse Industry Stock Comparison
Buy
68
EYPT
EyePoint Pharmaceuticals
Last Price:
9.18
Seasonality Move:
-10.5%
Buy
76
BELFB
Bel Fuse
Last Price:
80.89
Seasonality Move:
13.94%
Buy
68
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $9.18. The Score for EYPT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
76
Bel Fuse (BELFB)
is a Buy
Is Bel Fuse a Buy, Sell or Hold?
- The current Bel Fuse [BELFB] share price is $81.03. The Score for BELFB is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- BELFB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $9.18
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 56.5 | Buy |
| Chaikin Money Flow: | -434949 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.11 - 9.07) | Buy |
| Bollinger Bands (100): | (7.53 - 12.27) | Sell |
BELFB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 77.85 | Buy |
| Chaikin Money Flow: | 207452 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.15 - 69.97) | Buy |
| Bollinger Bands (100): | (62.12 - 69.5) | Buy |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.74 | Buy |
| 20-day SMA: | 8.69 | Buy |
| 50-day SMA: | 8.9 | Buy |
| 200-day SMA: | 16.43 | Sell |
| 8-day EMA: | 8.82 | Buy |
| 20-day EMA: | 8.69 | Buy |
| 50-day EMA: | 9.08 | Buy |
| 200-day EMA: | 12.35 | Sell |
BELFB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.56 | Buy |
| 20-day SMA: | 66.99 | Buy |
| 50-day SMA: | 67.04 | Buy |
| 200-day SMA: | 63.64 | Buy |
| 8-day EMA: | 70.81 | Buy |
| 20-day EMA: | 68.04 | Buy |
| 50-day EMA: | 66.68 | Buy |
| 200-day EMA: | 62.24 | Buy |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Bel Fuse Earnings Growth & BELFB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.66 per share, a decrease this year of $1.89 per share, and an increase next year of $0.28 per share.
EyePoint Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bel Fuse Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||